Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction

Basic Research in Cardiology

Volumn 110, Issue 3, 2015, Pages

  Bao, Ming Wei ^a,b   Cai, Zhongxiang ^a,b   Zhang, Xiao Jing ^c   Li, Liangpeng ^d   Liu, Xiaoxiong ^a,b   Wan, Nian ^a,b   Hu, Gangying ^a,b   Wan, Fengwei ^e   Zhang, Rui ^b   Zhu, Xueyong ^b   Xia, Hao ^a,b   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c University of Macau   (Macao)

^d NANJING MEDICAL UNIVERSITY   (China)

^e Gen Hosp People's Liberation Army   (China)

Author keywords

Apoptosis; ASK1; Cardiac remodelling; DKK3; Inflammation; Myocardial infarction

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; DICKKOPF 3 PROTEIN; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; DKK3 PROTEIN, HUMAN; DKK3 PROTEIN, MOUSE; DKK3 PROTEIN, RAT; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOVASCULAR MORTALITY; CELL HYPOXIA; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HEART DISEASE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICULAR REMODELLING; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; HEART VENTRICLE REMODELING; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUNEL ASSAY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU NICK-END LABELING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84930958875     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0481-x     Document Type: Article

References (52)

1. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H, Huh NH (2005) Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65:9617–9622. doi:10.1158/0008-5472.CAN-05-0829
2. Abe J, Baines CP, Berk BC (2000) Role of mitogen-activated protein kinases in ischemia and reperfusion injury: the good and the bad. Circ Res 86:607–609
3. Barancik M, Htun P, Strohm C, Kilian S, Schaper W (2000) Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol 35:474–483
4. Barrantes Idel B, Montero-Pedrazuela A, Guadano-Ferraz A, Obregon MJ, Martinez de Mena R, Gailus-Durner V, Fuchs H, Franz TJ, Kalaydjiev S, Klempt M, Holter S, Rathkolb B, Reinhard C, Morreale de Escobar G, Bernal J, Busch DH, Wurst W, Wolf E, Schulz H, Shtrom S, Greiner E, Hrabe de Angelis M, Westphal H, Niehrs C (2006) Generation and characterization of dickkopf3 mutant mice. Mol Cell Biol 26:2317–2326. doi:10.1128/MCB.26.6.2317-2326.2006
5. Bharti K, Gasper M, Ou J, Brucato M, Clore-Gronenborn K, Pickel J, Arnheiter H (2012) A regulatory loop involving PAX6, MITF, and WNT signaling controls retinal pigment epithelium development. PLoS Genet 8:e1002757. doi:10.1371/journal.pgen.1002757
6. Chen K, Gao L, Liu Y, Zhang Y, Jiang DS, Wei X, Zhu XH, Zhang R, Chen Y, Yang Q, Kioka N, Zhang XD, Li H (2013) Vinexin-beta protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway. Basic Res Cardiol 108:338. doi:10.1007/s00395-013-0338-0
7. Dorn GW 2nd (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81:465–473. doi:10.1093/cvr/cvn243
8. Dorn GW 2nd (2009) Novel pharmacotherapies to abrogate postinfarction ventricular remodeling. Nat Rev Cardiol 6:283–291. doi:10.1038/nrcardio.2009.12
9. Engelbrecht AM, Niesler C, Page C, Lochner A (2004) p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res Cardiol 99:338–350. doi:10.1007/s00395-004-0478-3
10. Frangogiannis NG (2014) The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255–265. doi:10.1038/nrcardio.2014.28
11. Frantz S, Bauersachs J, Ertl G (2009) Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 81:474–481. doi:10.1093/cvr/cvn292
12. Ghosh S, Hayden MS (2008) New regulators of NF-κB in inflammation. Nat Rev Immunol 8:837–848. doi:10.1038/nri2423
13. Gordon JW, Shaw JA, Kirshenbaum LA (2011) Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 108:1122–1132. doi:10.1161/CIRCRESAHA.110.226928
14. Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD (2011) Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res 89:129–138. doi:10.1093/cvr/cvq274
15. Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. doi:10.1016/S0140-6736(14)60107-0
16. Heusch P, Canton M, Aker S, van de Sand A, Konietzka I, Rassaf T, Menazza S, Brodde OE, Di Lisa F, Heusch G, Schulz R (2010) The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits. Br J Pharmacol 160:1408–1416. doi:10.1111/j.1476-5381.2010.00793.x
17. Hreniuk D, Garay M, Gaarde W, Monia BP, McKay RA, Cioffi CL (2001) Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 59:867–874
18. Jiang DS, Bian ZY, Zhang Y, Zhang SM, Liu Y, Zhang R, Chen Y, Yang Q, Zhang XD, Fan GC, Li H (2013) Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61:1193–1202. doi:10.1161/HYPERTENSIONAHA.111.00614
19. Jiang DS, Li L, Huang L, Gong J, Xia H, Liu X, Wan N, Wei X, Zhu X, Chen Y, Chen X, Zhang XD, Li H (2014) Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload. Hypertension 64:77–86. doi:10.1161/HYPERTENSIONAHA.114.03229
20. Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y, Chen K, Gao L, Zhou H, Zhu XH, Liu PP, Bond Lau W, Ma X, Zou Y, Zhang XD, Fan GC, Li H (2014) IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun 5:3303. doi:10.1038/ncomms4303
21. Jiang DS, Zhang XF, Gao L, Zong J, Zhou H, Liu Y, Zhang Y, Bian ZY, Zhu LH, Fan GC, Zhang XD, Li H (2014) Signal regulatory protein-alpha protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling. Hypertension 63:96–104. doi:10.1161/HYPERTENSIONAHA.113.01506
22. Joffe SW, Webster K, McManus DD, Kiernan MS, Lessard D, Yarzebski J, Darling C, Gore JM, Goldberg RJ (2013) Improved survival after heart failure: a community-based perspective. J Am Heart Assoc 2:e000053. doi:10.1161/JAHA.113.000053
23. Kaiser RA, Liang Q, Bueno O, Huang Y, Lackey T, Klevitsky R, Hewett TE, Molkentin JD (2005) Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia–reperfusion-induced cell death in vivo. J Biol Chem 280:32602–32608. doi:10.1074/jbc.M500684200
24. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM (2006) Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25:6528–6537. doi:10.1038/sj.onc.1209661
25. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J, Chae M, Zhang W, Lee JH (2009) Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 124:287–297. doi:10.1002/ijc.23913
26. Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, Yang Q, Huang Y, Wei YS, Liu PP, Liu DP, Liang CC (2007) Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 115:1885–1894. doi:10.1161/CIRCULATIONAHA.106.656835
27. Liu Q, Sargent MA, York AJ, Molkentin JD (2009) ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice. Circ Res 105:1110–1117. doi:10.1161/CIRCRESAHA.109.200741
28. Lu J, Bian ZY, Zhang R, Zhang Y, Liu C, Yan L, Zhang SM, Jiang DS, Wei X, Zhu XH, Chen M, Wang AB, Chen Y, Yang Q, Liu PP, Li H (2013) Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res Cardiol 108:326. doi:10.1007/s00395-012-0326-9
29. Mallarino R, Campas O, Fritz JA, Burns KJ, Weeks OG, Brenner MP, Abzhanov A (2012) Closely related bird species demonstrate flexibility between beak morphology and underlying developmental programs. Proc Natl Acad Sci USA 109:16222–16227. doi:10.1073/pnas.1206205109
30. Muslin AJ (2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond) 115:203–218. doi:10.1042/CS20070430
31. Nakamura RE, Hunter DD, Yi H, Brunken WJ, Hackam AS (2007) Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. BMC Cell Biol 8:52. doi:10.1186/1471-2121-8-52
32. Nian M, Lee P, Khaper N, Liu P (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:1543–1553. doi:10.1161/01.RES.0000130526.20854.fa
33. Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469–7481. doi:10.1038/sj.onc.1210054
34. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA (2006) Controversies in ventricular remodelling. Lancet 367:356–367. doi:10.1016/S0140-6736(06)68074-4
35. Papatriantafyllou M, Moldenhauer G, Ludwig J, Tafuri A, Garbi N, Hollmann G, Kublbeck G, Klevenz A, Schmitt S, Pougialis G, Niehrs C, Grone HJ, Hammerling GJ, Arnold B, Oelert T (2012) Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance. Proc Natl Acad Sci USA 109:1631–1636. doi:10.1073/pnas.1115980109
36. Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507–1546. doi:10.1152/physrev.00054.2009
37. Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G (2002) p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55:690–700
38. Shen DF, Tang QZ, Yan L, Zhang Y, Zhu LH, Wang L, Liu C, Bian ZY, Li H (2010) Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling. Br J Pharmacol 159:970–981. doi:10.1111/j.1476-5381.2009.00605.x
39. Shishido T, Nozaki N, Yamaguchi S, Shibata Y, Nitobe J, Miyamoto T, Takahashi H, Arimoto T, Maeda K, Yamakawa M, Takeuchi O, Akira S, Takeishi Y, Kubota I (2003) Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2905–2910. doi:10.1161/01.CIR.0000101921.93016.1C
40. Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981–2988
41. Takeda K, Matsuzawa A, Nishitoh H, Ichijo H (2003) Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 28:23–29
42. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Joint ESCAAHAWHFTFftUDoMI (2012) Third universal definition of myocardial infarction. Circulation 126:2020–2035. doi:10.1161/CIR.0b013e31826e1058
43. Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, de Kleijn DP (2012) The innate immune response in reperfused myocardium. Cardiovasc Res 94:276–283. doi:10.1093/cvr/cvs018
44. Tudzarova S, Trotter MW, Wollenschlaeger A, Mulvey C, Godovac-Zimmermann J, Williams GH, Stoeber K (2010) Molecular architecture of the DNA replication origin activation checkpoint. EMBO J 29:3381–3394. doi:10.1038/emboj.2010.201
45. Urashima T, Zhao M, Wagner R, Fajardo G, Farahani S, Quertermous T, Bernstein D (2008) Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol 295:H1351–H1368. doi:10.1152/ajpheart.91526.2007
46. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7:30–37. doi:10.1038/nrcardio.2009.199
47. Wysoczynski M, Solanki M, Borkowska S, van Hoose P, Brittian KR, Prabhu SD, Ratajczak MZ, Rokosh G (2014) Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction. Stem Cells 32:2502–2515. doi:10.1002/stem.1743
48. Xiao J, Moon M, Yan L, Nian M, Zhang Y, Liu C, Lu J, Guan H, Chen M, Jiang D, Jiang H, Liu PP, Li H (2012) Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction. Basic Res Cardiol 107:239. doi:10.1007/s00395-011-0239-z
49. Yamaguchi O, Higuchi Y, Hirotani S, Kashiwase K, Nakayama H, Hikoso S, Takeda T, Watanabe T, Asahi M, Taniike M, Matsumura Y, Tsujimoto I, Hongo K, Kusakari Y, Kurihara S, Nishida K, Ichijo H, Hori M, Otsu K (2003) Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 100:15883–15888. doi:10.1073/pnas.2136717100
50. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH (2000) Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86:692–699
51. Zhang Y, Liu X, She ZG, Jiang DS, Wan N, Xia H, Zhu XH, Wei X, Zhang XD, Li H (2014) Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury. Basic Res Cardiol 109:434. doi:10.1007/s00395-014-0434-9
52. Zhang Y, Liu Y, Zhu XH, Zhang XD, Jiang DS, Bian ZY, Zhang XF, Chen K, Wei X, Gao L, Zhu LH, Yang Q, Fan GC, Lau WB, Ma X, Li H (2014) Dickkopf-3 attenuates pressure overload-induced cardiac remodelling. Cardiovasc Res 102:35–45. doi:10.1093/cvr/cvu004